2.40
Cytomx Therapeutics Inc (CTMX) 最新ニュース
What are analysts’ price targets for CytomX Therapeutics Inc. in the next 12 monthsFree Wealth Planning Blueprint - jammulinksnews.com
What institutional investors are buying CytomX Therapeutics Inc. stockGet expert analysis on top stock picks - jammulinksnews.com
How strong is CytomX Therapeutics Inc. company’s balance sheetNavigate market volatility with smart strategies - jammulinksnews.com
What makes CytomX Therapeutics Inc. stock price move sharplyFree Access to Community with 300% Return - Metal.it
What drives CytomX Therapeutics Inc. stock priceStrong return on assets - PrintWeekIndia
CytomX (CTMX) Shares Promising Early Results for CRC Drug Candidate - Yahoo Finance
What analysts say about CytomX Therapeutics Inc. stockSkyrocketing returns - PrintWeekIndia
CytomX Therapeutics Inc. Stock Analysis and ForecastExceptional return forecasts - Autocar Professional
10 Best Performing Penny Stocks So Far in 2025 - Insider Monkey
Is CytomX Therapeutics Inc. a good long term investmentFree Stock Market Return Analysis - Autocar Professional
Why CytomX Therapeutics Inc. stock attracts strong analyst attentionBalanced Risk Reward Portfolio - Newser
How CytomX Therapeutics Inc. stock performs during market volatilityProtected Capital Trading Plan - Newser
The Future of Allogene Therapeutics Inc: Analyzing ALLO - investchronicle.com
Pliant Therapeutics Inc (PLRX) Stock: Navigating a Year of Volatility - investchronicle.com
CTMX SEC FilingsCytomx Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Do CytomX Therapeutics' (NASDAQ:CTMX) Earnings Warrant Your Attention? - Yahoo Finance
CytomX Q2 2025 presentation slides: CX-2051 shows promising Phase 1 results in CRC By Investing.com - Investing.com South Africa
CytomX Q2 2025 presentation slides: CX-2051 shows promising Phase 1 results in CRC - Investing.com
Certain Pre-Funded warrants of CytomX Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 26-JUN-2025. - MarketScreener
CytomX Therapeutics Executives Sell Shares to Cover Tax Obligations - TradingView
CytomX Therapeutics CEO Sells Shares to Meet Tax Obligations - TradingView
CytomX Therapeutics Approves Key Amendments at Annual Meeting - TipRanks
Stocks in play: Roots Corp. - The Globe and Mail
大文字化:
|
ボリューム (24 時間):